Assessment of What Patients and Healthcare Providers Value
Study Details
Study Description
Brief Summary
To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
PRIMARY OBJECTIVE:
- To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience).
SECONDARY OBJECTIVES:
-
To assess which attributes of value (i.e., outcomes, QOL, cost, experience) health care providers (i.e., physicians, nurses, administrators) feel are most important in health care delivery.
-
To assess how these patients' views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
-
To assess how patients' view differ to health providers.
OUTLINE:
Patients and healthcare providers complete a survey over 10-15 minutes.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Observational (survey administration) Patients and healthcare providers complete a survey over 10-15 minutes. |
Other: Survey Administration
Complete survey
|
Outcome Measures
Primary Outcome Measures
- Importance patients place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience) [Survey completion up to 1 year]
We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.
Secondary Outcome Measures
- Most important attributes of value to healthcare providers [Survey completion up to 1 year]
Provider characteristics and survey items will be summarized using descriptive statistics, including means, SDs, proportions, range, and 95% CIs, etc.
- Importance care providers (i.e., physicians, nurses, administrators) place on each of the attributes of value (i.e., outcomes, quality of life [QOL], cost, experience) [Survey completion up to 1 year]
Chi-square tests (or Fisher's exact test) will be used to compare the results between patients and providers.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Any patient who has been treated, or is anticipated to be treated, for potentially resectable, biopsy-proven pancreatic adenocarcinoma, pancreatic neuroendocrine malignancy, or gastric adenocarcinoma
-
Providers involved in the care of gastric and pancreatic cancer patients. Providers will include non-collaborative surgical oncologists, medical oncologists, radiation oncologists, administrators, nurses, mid-level providers
-
Able to understand the description of the study and willing to participate
Exclusion Criteria:
- Inability to read and answer questions in English
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | M D Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Matthew H Katz, M.D. Anderson Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2020-0211
- NCI-2020-04577
- 2020-0211
- P30CA016672